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We have recently shown that the trichodysplasia spinulosa-associated polyomavirus (TSPyV) belongs to a
large monophyletic group of mammalian polyomaviruses that experienced accelerated codon-
constrained Val-Ala (COCO-VA) toggling at a protein site common to both Middle and Alternative T-
antigens (MT/ALTO). Here we analyzed thirteen, mostly newly sequenced TSPyV genomes, representing
40% of reported TS disease cases world-wide. We found two deletions and 30 variable sites (r0.6%)
that included only four sites with non-synonymous substitutions (NSS). One NSS site was under positive
selection in the exon shared by Small and Middle T antigens, while three others were segregated in MT/
ALTO. Two MT/ALTO sites covaried with ﬁve sites elsewhere in the genome and determined separation of
twelve TSPyVs into two most populous phylogenetic lineages. The other, most distant TSPyV was dis-
tinguished by NSS at the COCO-VA site, observed for the ﬁrst time during intra-species evolution. Our
ﬁndings reveal a connection between micro- and macro-evolution of polyomaviruses.
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The fast growing Polyomaviridae family includes viruses infect-
ing diverse vertebrate species. Phylogenetically this family can be
divided into avian and mammalian polyomaviruses (Decaprio and
Garcia, 2013; Feltkamp et al., 2013; Johne et al., 2011). The latter are
represented by four monophyletic genogroups (Carter et al., 2013;
Feltkamp et al., 2013; Johne et al., 2011), and a proposal for
accommodation of this diversity in virus taxonomy at the genus and
species levels is currently pending (Calvignac-Spencer et al., 2015).
The large Orthopolyomavirus-I (Ortho-I) genogroup includes mouse
(MPyV), hamster (HaPyV), the Merkel cell (MCPyV), and tricho-
dysplasia spinulosa-associated polyomaviruses (TSPyV) among
many others (Feltkamp et al., 2013; Feng et al., 2008; Johne et al.,
2011; Korup
et al., 2013; Mishra et al., 2014). Most other studied mammalian
polyomaviruses, including BK polyomavirus (BKPyV), JC poly-
omavirus (JCPyV) and Simian virus 40 (SV40), belong to the
Orthopolyomavirus-II (Ortho-II) genogroup, while the majority of
recently identiﬁed human polyomaviruses (Allander et al., 2007;
Buck et al., 2012; Gaynor et al., 2007; Lim et al., 2013; Sauvage et al.,
2011; Schowalter et al., 2010; Scuda et al., 2011; Siebrasse et al.,
2012b; Yu et al., 2012) belong to either the Malawipolyomavirus
(Malawi) or the Wukipolyomavirus (Wuki) genogroups (Feltkamp
et al., 2013; Johne et al., 2011).
Humans are commonly infected with polyomaviruses at young
age after which a persistent, latent infection sets in before the virus
reactivates, typically when the immune system is compromised
(DeCaprio et al., 2013). Polyomaviruses use small circular double
stranded DNA genomes with two non-overlapping protein-coding
regions that are expressed either early or late in infection (Jiang et al.,Fig. 1. Genome organization and variation, and putative transcriptome of TSPyV. This ﬁgu
the key inset at top right. The inner layer depicts the six reading frames of the TSPyV gen
frame 1 at the last nucleotide in reverse direction; the ﬁve largest ORFs are indicated by
shadings The intermediate layer depicts SNPs as circles of three shades: gray, SNPs in NCCR
non-synonymous substitutions. Note the duality of the substitutions in the ORF2/ORF5 ov
range symbols. The outer layer depicts predicted primary and spliced transcripts; their cod
predicted introns are shown as solid and dashed lines, respectively. Abbreviations: primar2009; White et al., 2009). Each region includes two ubiquitous open
reading frames (ORF), which we named ORF1-ORF2, and ORF3-ORF4,
respectively (Lauber et al., 2015) (Fig. 1). They are separated by the
non-coding control region (NCCR) and the intergenic region (IR), and
expressed through alternative splicing of the primary transcripts to
produce the early Small and Large T-antigens (ST and LT) (White et al.,
2009) and the late capsid proteins (VP1 and VP2/VP3), respectively
(Shishido-Hara et al., 2000).
Additionally, all but three viruses of the Ortho-I genogroup
encode ORF5 (a.k.a. Alternate frame of the Large T Open reading
frame, ALTO). These polyomaviruses are known as Almi (Carter
et al., 2013) or ORF5-plus (Lauber et al., 2015). ORF5 largely overlaps
with the 50-terminal region of ORF2, which, unlike ORF5, is encoded
by all mammalian polyomaviruses. Because of this notable differ-
ence in the phyletic range of viruses, ORF2 is considered ancestral,
while ORF5 is labeled “de novo” to indicate that it may have
emerged by overprinting of the ancestral ORF (Carter et al., 2013;
Lauber et al., 2015). ORF5 is merged with ORF1 in a spliced tran-
script that directs the synthesis of Middle T-antigen (MT) in rodent
PyVs (Cheng et al., 2009; Courtneidge et al., 1991; Fluck and
Schaffhausen, 2009; Hutchinson et al., 1978) and TSPyV (van der
Meijden et al., 2015). It is expressed also alone as ALTO protein in
MCPyV (Carter et al., 2013) and TSPyV (van der Meijden et al., 2015).
The ORF5 is extremely diverged in the ORF5-plus/Almi viruses,
with only four short motifs [ORF5m1-ORF5m4 according to the
designation by Lauber et al. (2015)] being conserved. Evolution of
these motifs is strongly constrained by four most conserved motifs
in the overlapping ancestral ORF2, which are encoded by the same
genomic regions but in a different reading frame (Carter et al.,
2013; Lauber et al., 2015). Overall, the ORF5-encoded part of MT/
ALTO is enriched with Pro residues (Magnusson et al., 1981; Yi andre has three circular layers, inner, intermediate, and outer, respectively, as detailed in
ome, frame þ1 starts at the ﬁrst nucleotide of the linearized genome clock-wise and
colors; the non-coding regions (NCCR and IR) of the genome are highlighted by white
and IR; white, synonymous substitutions; colored (according to the respective ORF),
erlapping region that were colored accordingly. Deletions in the NCCR are shown as
ing parts are colored according to the respective ORFs, while untranslated regions and
yT1, primary transcript for early genes; primaryT2, primary transcript for late genes.
S. Kazem et al. / Virology 487 (2016) 129–140 131Freund, 1998) and may largely be intrinsically disordered (Carter
et al., 2013; Lauber et al., 2015). Its ORF5m4 motif corresponds to a
C-terminal transmembrane domain (Courtneidge et al., 1991) that
is essential for the transforming properties of MT in rodents
(Cheng et al., 2009). This function and interaction of MT with
different cellular proteins may be modulated by phosphorylation
at several Ser, Thr and Tyr residues as shown for MPyV (Fluck and
Schaffhausen, 2009).
The human polyomavirus genome could diverge by as much as
5.3% upon virus circulation in the host population, as was shown for
Malawi polyomavirus (MWPyV) (Siebrasse et al., 2012a), and 0.55%
within an individual, as was shown for BKPyV (Chen et al., 2004), with
mutations preferentially accumulating in the NCCR (Gosert et al.,
2008; Yogo et al., 2008). We have recently revealed that evolution of
Ortho-I polyomaviruses, including all ORF5-plus viruses, is accom-
panied by an accelerated toggling between Ala and Val residues at a
position in ORF5m2 motif (Lauber et al., 2015). It was named Codon-
Constrained Val-Ala (COCO-VA) toggling to reﬂect the strict constraint
imposed by the conserved Cys residue of the LXCXE pRB-bindingmotif
in the overlapping ORF2 and the binary choice of the residues involved
in toggling. The observed toggling rate approaches the virus speciation
rate in the Ortho-I polyomaviruses indicating that it is much higher
than expected under the model of neutral evolution. Consequently, the
COCO-VA site may be under positive selection in all Ortho-I poly-
omaviruses and may accompany or drive inter-species adaptation of
these viruses.
Commonly, virus adaptation is studied at the intra-species level
and requires sampling of circulating populations to identify sites
under positive selection. For Ortho-I polyomaviruses, a relatively
sizable sampling is available only for MCPyV (Carter et al., 2013).
However, the majority of sequenced MCPyVs are obtained from
viruses integrated into the genome of Merkel cell carcinomas
which encode the N-terminally truncated LT and thus have
defective ORF5-encoding products. Accordingly, the known
MCPyV genomes are no good representative for Ortho-I poly-
omaviruses regarding ORF5 evolution. To address this gap in our
knowledge, we sought to characterize the natural diversity of
TSPyV, which is associated with the rare skin disease - tricho-
dysplasia spinulosa (TS) - exclusively seen in severely immuno-
compromized patients (Blake et al., 2011; Burns et al., 2011;
Haycox et al., 1999; Kazem et al., 2012; Matthews et al., 2011;
Schwieger-Briel et al., 2010; van der Meijden et al., 2010). EtiologicTable 1
Overview of all TSPyV genomes analyzed in this study.
Name isolatea Origin Sample treatment
TSPyV-0109 NLD3, ‘s Hertogenbosch (Noord-Brabant) FRFRc
TSPyV-0203 AUS, Nedlands (Western Australia) FFPE
TSPyV-0304 USA, New York (New York) FFPE
TSPyV-0409 USA, Cleveland (Ohio) FFPE
TSPyV-0510 USA, Cleveland (Ohio) FFPE
TSPyV-0602 USA, Birmingham (Alabama) FFPE
TSPyV-0797 USA, Birmingham (Alabama) FFPE
TSPyV-0807 CAN, Toronto (Ontario) FFPE
TSPyV-0910 USA, Dallas (Texas) FFPE
TSPyV-1008 USA, Charleston (South Carolina) FFPE
TSPyV-1197 USA, Seattle (Washington) FFPE
TSPyV-1211 NLD, Rotterdam (Zuid-Holland) FFPE
TSPyV-1312 USA, Dallas (Texas) FFPE
TSPyV-1412 AUS, Melbourne (Victoria) FRFR
TSPyV-WK164 USA, St. Louis (Missouri) –
a The ﬁrst two digits correspond to the trichodysplasia spinulosa (TS) sample numbe
the year of sampling ranging from 1997 (xx97) to 2012 (xx12). TSPyV-WK164 was isola
b TSPyV-load is shown in virus copies/cell, as was calculated and reported previously
was calculated per mL (Siebrasse et al., 2012a).
c Abbreviations: NLD, The Netherlands, AUS, Australia; USA, United States of Americ
d Attempts to amplify sequences failed, possibly due to either low viral load (TSPyVinvolvement of TSPyV in TS is evident from high viral load and
antigen expression in affected skin (Kazem et al., 2012) and pos-
sible disruption of cell-cycle control by T-antigen(s) (Kazem et al.,
2014). TSPyV is globally circulating with seroprevalences of
approximately 70% in the general adult population, as demon-
strated in Europe (Chen et al., 2011; van der Meijden et al., 2011),
Australia (van der Meijden et al., 2013) and Asia (Fukumoto
et al., 2015). In asymptomatic individuals, healthy and immuno-
compromised, TSPyV DNA is seldom detected (Kazem et al., 2012,
2013; Scuda et al., 2011; Wieland et al., 2014).
In this report we describe evolutionary analysis of 13 TSPyV
genomes, mostly newly sequenced and representing 40% of the
reported TS cases at three continents (Kazem et al., 2013b). We
demonstrate a disproportionally large fraction of otherwise very
limited genetic variation in the NCCR. In the coding regions only
four sites accepting non-synonymous substitutions were identiﬁed.
A single one in ORF1 was found to be under positive selection, while
the three others are segregated in the MT- and ALTO-encoding
ORF5. Importantly, one of these, which may have accepted a sub-
stitution most early in the TSPyV evolution, involves the COCO-VA
site, and represents the ﬁrst case of intra-species residue toggling at
this site described so far in a polyomavirus. Thus, the presented
results combined with those we published elsewhere (Lauber et al.,
2015) reveal a connection between micro- and macro-evolution of
polyomaviruses and establish TSPyV as a virus to study this
connection.Results
TSPyV diverged by substitution across the entire genome and deletion
in NCCR
To gain insight into the evolution of TSPyV during circulation in
the human population, we sequenced and analyzed genomes of a
representative set of this virus. The viral genomic DNA sequences
were obtained from thirteen TS lesional samples, which were
collected over 16 years from largely previously described TS
patients residing in Northern America, the Netherlands, and Aus-
tralia (Table 1). Sample DNA was subjected to 18 different TSPyV-
speciﬁc PCR reactions to obtain amplicons that covered the entire
TSPyV genome. The target sequences were ampliﬁed and theTSPyV DNA-loadb GenBank Ref. seq. Reference
7.2x104 NC_014361 van der Meijden et al. (2010)
7.6x105 KF444091 (Sadler et al., (2007)
4.5x106 KF444092 Wyatt et al. (2005)
1.2x105 KF444093 Kazem et al. (2012)
4.4x106 KF444094 Kazem et al. (2012)
6.3x104 KF444095 Kazem et al. (2012)
7.8x101 –d Holzer and Hughey (2009)
5.1x104 –d Schwieger-Briel et al. (2010)
1.4x106 KF444096 Matthews et al. (2011)
5.6x105 KF444097 Benoit et al. (2010)
1.7x106 KF444098 Haycox et al. (1999)
2.8x104 KF444099 This study
2.1x104 KF444100 This study
9.4x104 KF444101 This study
2.4x104 JQ723730 Siebrasse et al. (2012a)
r used to describe the TS patients in (Kazem et al., 2012). The last two digits indicate
ted in 2009 (Siebrasse et al., 2012a).
(Kazem et al., 2012; van der Meijden et al., 2010). For TSPyV-WK164 the virus copies
a; CAN, Canada; FRFR, fresh frozen; FFPE, formalin-ﬁxed parafﬁn embedded.
-0797) or poor DNA quality (TSPyV-0807).
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Fig. 2. Cumulative number of single nucleotide substitutions in TSPyV pairs. For
brevity, the “TSPyV” label was omitted from the virus names. Deletions were
excluded upon the distance calculation. Due to diagonal symmetry, distances in the
lower triangle of matrix are not shown. Intra-lineage values for the three TSPyV
lineages (TSI-TSIII; see text below) are highlighted by gray background. Pairs with
none or one substitution are in bold.
S. Kazem et al. / Virology 487 (2016) 129–140132products visualized on gel (Fig. S1). Subsequent cloning, sequen-
cing and assembling of the amplicons of every isolate resulted in
eleven complete circular contigs, each representing a TSPyV gen-
ome. These genomes, together with the previously reported
TSPyV-WK164 (Siebrasse et al., 2012a) and TSPyV-0109 (van derConsensus
TSPyV-0109
TSPyV-0203
TSPyV-0304
TSPyV-0409
TSPyV-0510
TSPyV-0602
TSPyV-0910
TSPyV-1008
TSPyV-1197
TSPyV-1211
TSPyV-1312
TSPyV-1412
TSPyV-WK164
NCCR ORF3 ORF4 ORF2 ORF1IR
ORF5
Δ
C C G GTTTCGAGTCCAATCCAATTCAGGG GA
A
T
A
A
A
A
A
A
A
A
A
A
A
T
C
C
C
C
C
T C C
C
C
C
C
C
T
T
T
T
G T
T
T
T
C
G
T
T
T
T
T
T
T
T
T
G
G
G
G
G
G
ACCATG
C
C
C
C
C
A
A
G
G
G
G
G
A
A
A
Δ
Δ
51
37
12 99 15
8
16
1
22
4
23
0
87
1
92
2
14
09
15
77
16
07
18
29
18
53
19
67
21
56
24
59
27
50
28
67
30
14
31
01
31
31
31
37
36
20
37
79
38
84
41
45
42
50
42
59
46
38
Fig. 3. Nucleotide and amino acid variation in TSPyV. (A) Alignment of SNPs and deletion
nucleotide. Bottom, nucleotide variation in TSPyV isolates: dots, nucleotides identical to the c
nts (61–99; TSPyV-1312). Gray shaded part, SNPs resulting in amino acid variations. (B) Ami
dinucleotides along with the affected ORF-speciﬁc codons. Bottom, the SNP-containing codMeijden et al., 2010) formed dataset 1 (DS1, see M&M). Analysis of
these genomes revealed that the total number of substitutions
separating TSPyV pairs was small, in the range from zero to twenty
(Fig. 2). They were conﬁned to 30 single nucleotide polymorphism
(SNP) sites across the entire 5232 nt genome (o0.6% variation),
each involving only two of the four possible alleles (see next).
Furthermore, genomes of TSPyV-0602 and TSPyV-1312 were found
to be, respectively, 39 and 54 nt shorter than genomes of the other
viruses. According to phylogenetic analysis of TSPyV (see below),
these isolates bifurcated relatively late in the evolution of TSPyV
implying that the observed size differences are likely due to
separate genomic deletions, and hereafter are labeled accordingly.
All SNPs and deletions were mapped on the TSPyV circular gen-
ome to link themwith coding and non-coding regions (Fig. 1, internal
and intermediate circles; Fig. 3A) (Lauber et al., 2015) and (putative)
expression products (spliced transcripts) (Fig. 1, external circle) (see
also (van der Meijden et al., 2015). Like with other human poly-
omaviruses (e.g., JCPyV and BKPyV) (Gosert et al., 2008; Yogo et al.,
2008), a disproportionally large fraction of the SNPs (7 of 30; 23%)
was located in the NCCR that comprises only 12% of the genome
(603 of 5232 nts). Three of these SNPs are also part of the non-
overlapping deletions found in TSPyV-0602 (two SNPs) and TSPyV-
1312 (one SNP). The identiﬁed SNPs and deletions are located outside
of counterparts of the known essential functional signals, such as the
pentanucleotide enhancer elements GAGGC and reversed GCCTC
(Fig. S3). The other non-coding region, the IR of 100 nts around
genomic position 2500 separating the 30-termini of the early and late
transcripts, contained one SNP (Figs. 1 and 3A). Nine SNPs were
identiﬁed in the late genomic region of 2032 bp: seven in ORF4 and
two in ORF3, respectively. Further twelve SNPs were found in the
early genomic region of 2507 bp: one in ORF1, three in the overlap
between ORF2 and ORF5, and eight in the unique part of ORF2. The
early region variations are expected to be expressed from one or
more transcripts (van der Meijden et al., 2015). All twenty SNPs in LT
ORF2 and in the VP ORFs represented synonymous substitutions. The-1
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S. Kazem et al. / Virology 487 (2016) 129–140 133three SNPs in the ORF2/ORF5 overlap were synonymous for the LT
ORF2 but non-synonymous for the MT/ALTO ORF5. The one SNP in
the ST/MT-speciﬁc part (exon) of ORF1 was also non-synonymous
(Figs. 1 and 3B).
Phylogenetic inference reveals two populous and one single-virus
lineages of TSPyV
Next we sought to infer the phylogenetic history of TSPyVs, a
task which presented several challenges.
Firstly, we needed to exclude a signiﬁcant contribution of
recombination during TSPyV evolution as this could mislead phy-
logeny reconstruction and downstream analyses. We have not
found consistent evidence for recombination using SBP and GARD
which were applied to several alignments of the TSPyV genomes
linearized at different genomic locations, since these programs may
not process alignments of circular genomes. Additionally, we have
noticed that seven covarying sites of TSPyV (see Figs. 3 and 4, and
below) are not genetically segregated, but rather distributed over
the entire genome in four different areas – NCCR, ORF4, the non-
overlapping part of ORF2, and ORF5. This pattern is compatible with
either no recombination or multiple recombination events. The
latter would be possible only if TSPyV recombines promiscuously to
the extent that recombination accounts for almost all variation
observed in the analyzed genomes. This seems highly unlikely given
that recombination was rarely observed in polyomaviruses.
Secondly, the current methods of choice for phylogeny recon-
struction are character-based Bayesian and Maximum-Likelihood
approaches, which require the selection of evolutionary models.
For analysis of TSPyV evolution, the viral genome should be par-
titioned into three parts including the non-coding NCCR and IR,
non-overlapping ORFs, and the overlapping ORF2/ORF5 regions
that are under different constraints and thus may evolve differ-
ently. However, this partitioning would limit further the already
very limited variation in the analyzed TSPyVs and thus undermine
the reliability of phylogenetic inference. Given these considera-
tions, we decided against partitioning the genome and in favor of
employing distance-based methods to verify Bayesian phylogeny
inferences. The major reservation against using distance-based
methods is their inability to account for repeated changes at sites.TSPy
TS I
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Fig. 4. Phylogeny and evolution of TSPyV. Presented is a TSPyV phylogeny, which was r
residence and four variable amino acid residues in MT and ST/MT are shown next to the v
0.05; Table 2) with lineages in the tree are indicated by asterisks (top). Support values fro
nodes inlets show reconstructed ancestral states of the four lineage-associated traits wWe considered this complication of relatively minor concern for
our analysis, given the small number of sites mutated (o0.6%).
Indeed as we learned subsequently (see below), only 10% of sites
may have experienced repeated changes (Figs. 3A and 4).
Using a Bayesian approach which was applied to dataset 2
(DS2, see M&M) that included 13 TSPyV variants together with
their closest relative, OraPyV1 (Groenewoud et al., 2010), we
inferred a rooted TSPyV tree with three monophyletic lineages
(TSI, TSII, and TSIII) of high probability support, with TSPyV-1312
being the sole representative of TSIII (not shown). A very similar
rooted tree was inferred using Neighbor-Joining and Minimum
Evolution algorithms, with the latter shown in Fig. 4. According to
the TSPyV tree, the intra-lineage scales of site variation in TSI and
TSII were in the comparable ranges from 0 to 5 and 1 to 4 SNPs,
respectively (Fig. 2). Differences between viruses of these lineages
were in the range from 7 to 13 sites, while TSPyV-1312 of TSIII
differs from other viruses in the range from 15 to 20 sites. This tree
enabled us to conduct several phylogeny-based analyses, including
ancestral reconstruction of AA states for sites that experienced
non-synonymous substitutions (Figs. 3 and 4).
Non-synonymous variation in the ST/MT antigen is under positive
selection
Next, we asked whether amino acid substitutions at the four
positions in the TSPyV variants (Fig. 3B) may have been accepted
under positive selection that would be indicative of adaptive
evolution of the virus to humans. To this end, we have applied a
McDonald–Kreitman test with Jukes&Cantor correction (MKT–JC)
as implemented at the MKT web-site (Egea et al., 2008) to align-
ments of the ﬁve ORF regions of the TSPyV genome, ORF1, non-
overlapping part of ORF2, the part of ORF2 overlapping with ORF5,
ORF4, and ORF5, respectively, that also included OraPyV1 as the
outgroup for TSPyV. In this statistical summary test, the number of
intra-TSPyV polymorphisms was compared to the inter-TSPyV-to-
OraPyV1 divergence, both at neutral and non-neutral sites, to
produce a 2x2 contingency Table for each ORF analyzed and to
assess the probability of selection (Table 2). Accordingly, ORF1 was
the only ORF identiﬁed as experiencing positive selection during
TSPyV evolution (p¼0.020). This TSPyV ORF region varies at theTSPyV-1312
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Table 2
Results of McDonald–Kreitman test with Jukes–Cantor correction.
ORF Dsa Dnb Psc Pnd p-valuee
ORF1 189.1 34.6 0 1 0.020
ORF2 overlap 34.9 23.2 2 0 0.254
ORF2 non-overlap 325.6 53.6 9 0 0.224
ORF4 346.6 111.3 7 0 0.134
ORF5 22.0 33.3 0 3 0.167
a JC-corrected number of divergent, synonymous substitutions.
b JC-corrected number of divergent, non-synonymous substitutions.
c JC-corrected number of polymorphic, synonymous substitutions.
d JC-corrected number of polymorphic, non-synonymous substitutions.
e Statistically signiﬁcant p value is in bold.
Table 3
Support values for phylogenetic associations of amino acid variations observed
among the 13 TSPyV isolates.
Support by criterionc
Variationa Genomic
positionb
Affected ORF AI PS MC
USA-NLD-AUS / / 0.143 1 0.121
H-Y 4638 ORF1 0.124 0.072 0.051
I-T 4259 ORF5 0 0.001 0.002
A-V 4250 ORF5 0 1 0.001
H-R 4145 ORF5 0 0 0.001
Negative
control
/ / 0.503 0.642 0.383
Positive control / / 0 0 0.001
a Country of origin: the home country of the patient; observed amino acid
variations: The respective amino acids are shown, separated by a dash; negative
control: To each tip of the phylogeny one of two arbitrary amino acids was assigned
randomly. The average p-value among 10 iterations is shown; positive control: Each
of the three TSPyV lineages was assigned a different amino acid, and each member
of the same lineage was assigned the same amino acid.
b Coordinate of the SNP causing the amino acid variation in the genome of
TSPyV-0109.
c p-values of the null hypothesis (random association of the amino acid var-
iation with the phylogeny) are shown for the following test statistics: association
index (AI), parsimony score (PS), maximum monophyletic clade size (MC). For MC,
the minimum value over the MC values of the single amino acid states is shown.
Signiﬁcant values under the conﬁdence level of α¼0.05 are in bold.
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genome starting from nucleotide position 1 in the NCCR counting
clock-wise), implying that the associated H133Y amino acid var-
iation (hereafter amino acid residue numbering is from the ﬁrst
common methionine in ORF1 shared by ST, MT and LT, see Fig. 1) in
the shared ST/MT domain may be under positive selection.
To verify this result, we conducted a second analysis which was
aimed at the detection of selection at individual sites. To this end, we
applied the random effect likelihood method (REL) and fast uncon-
strained Bayesian approximation method (FUBAR) (Kosakovsky Pond
and Frost, 2005a; Kosakovsky Pond and Muse, 2005b; Murrell et al.,
2013) to DS3, including a concatenated alignment of ﬁve ORF regions
of TSPyVs (see M&M for details). Again, positive selection was
favored only for the G4638A/H133Y variation in ORF1 by both REL
(probability support of 0.99) and FUBAR (0.95). According to the
rooted tree of TSPyV (Fig. 4) and ancestral state reconstruction, this
site was substituted three times during evolution from the ancestral
H133 state in the TSPyV MCRA through toggling between the alter-
nating H/Y residues. Under a model of neutral evolution, this number
is indeed high given that only o0.6% sites experienced change
during TSPyV evolution. At the isolate level, the changes of H133Y in
TSPyV-0602 of TSI and Y133H in TSPyV-1008 of TSII could be qua-
liﬁed as convergence to those residues that dominate the other
group. Besides the 4638 site, only two other sites, 1829 of ORF4 and
3101 of ORF2, respectively, (Figs. 3A and 4), may have experienced a
repeated change, which was synonymous for these sites.
Three non-synonymous SNPs in ORF5 are strongly associated with
three phylogenetic clusters of TSPyV and two of these co-vary with
ﬁve SNPs in other regions
The evidently small genetic diversity and size of our dataset
may limit the resolution power of the employed methods to assess
selection accurately at all sites (Kosakovsky Pond and Frost,
2005c). Additionally, identiﬁcation of positive selection in ORF5 is
complicated since evolution of this ORF is constrained by ORF2
(Lauber et al., 2015). Therefore, to gain further insight into the
evolution of non-synonymous substitutions, we used three sta-
tistical tests (see M&M) to estimate the association between a trait
(the amino acid variations in this case) and the phylogeny. We
reasoned that statistically signiﬁcant association would be indi-
cative for the analyzed sites being constrained in a lineage-speciﬁc
fashion, e.g. possibly selected (Kumar et al., 2012). Before con-
ducting these analyses, the three TSPyV lineages were reproduced
with a modiﬁed DS1 that did not include the SNPs with non-
synonymous substitutions (data not shown). This observation
implied that the observed lineages are independent from the MT/
ALTO codons encoding the I242T, A245V and H280R variation.
Consequently, the tree (Fig. 4) could be used in the association test.
All three amino acid variations in the ORF5 (but not that of
ORF1) were found to be signiﬁcantly associated (pr0.002) with thethree major phylogenetic lineages of TSPyV (Fig. 4): two variations
received support from three test statistics and one variation from
two statistics (Table 3). In contrast, no signiﬁcant association
between location (country) and phylogenetic lineage was found.
Given this strong association of the two variations, we then asked
whether the non-synonymous ORF5 SNPs coevolve with other
SNPs. To this end, we tested all pairs of the 30 SNPs (435 pairs in
total) for coevolution using a Bayesian evolutionary framework as
implemented in the Spidermonkey tool (Kosakovsky Pond and
Frost, 2005a; Poon et al., 2007). None of the identiﬁed networks
were supported with posterior probability values at the statistically
signiﬁcant level to indicate co-evolution, which was not surprising
given the limited size of the analyzed pool. Still and strikingly,
T4145C (H280R) and A4259G (I242T) variations were among two
out of the three networks (Fig. 5A) that received support values
within the top 2.7% of the posterior probabilities values for network
edges (Fig. 5B). For T4145C, the co-variable synonymous SNP
T1409C is located in the VP1 ORF4 supported with p¼0.53. For
T4259G, three co-variable SNPs (G99A, G161A, and G230C) are
located in the NCCR and one (synonymous A3131G) in the LT ORF2;
together they form a ﬁve-site network with every pair being con-
nected by an edge supported in the narrow range of probability
values of 0.32–0.37. The third network involves co-variation at the
two distantly located non-coding regions, the NCCR G158A and the
IR A2459T (Fig. 5A). It is observed only in TSPyV-0109 (Figs. 3A and
4) indicating a recent emergence.
According to parsimonious reasoning, amino acid changes at
the two sites in ORF5 that were part of the top networks, as well as
the covarying nucleotides outside ORF5, were most likely ﬁxed
during transition from the MRCA of TSI/TSII to the MRCA of TSI
(R280H) and TSII (I242T), respectively. This scenario was sup-
ported by sequence reconstruction of the ancestral trait states at
these sites with probability support values of 0.98 and 1.0 (Fig. 4).
It is noteworthy that the ancestral and the newly acquired sub-
stitutions persisted in all characterized variants of the respective
two lineages, TSI and TSII, respectively (Figs. 3 and 4).
In contrast, ancestral reconstruction for the MRCA of the TSPyV
root at the third ORF5 site, which is the COCO-VA site, was highly
uncertain (p¼0.5). The reason is an exclusive association of two
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Fig. 5. The genome-wide networks of covarying nucleotide sites. (A) The 12 top
scoring pairs (top 2.7%; see panel B) form three networks involving different types
of SNPs (nodes) deﬁned by color in Fig. 1 and numbered according to Fig. 3A. Each
edge is provided with its support value. (B) Distribution of the marginal posterior
probability of network edges. The histogram depicts the normalized distribution of
probability values for 435 pairs formed by the 30 SNPs using a bin size of 0.01. The
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have diverged from the MRCA of TSPyVs most early. If the TSI/TSII
allele (A245) was ancestral in all TSPyVs, then the A245V sub-
stitution may have happened at any time of divergence of TSIII. If
the V245 allele was ancestral, as depicted in Fig. 4, then the V245A
substitution was acquired during transition from the MRCA of
TSPyVs to the MRCA of TSI/TSII. While the ﬁrst compared to the
second evolutionary scenario leaves much larger uncertainty in
respect to when the substitution at position 245 occurred, both
scenarios agree that this substitution might have happened at an
early stage of the TSPyV divergence. That possibility seems parti-
cularly plausible in the second scenario which implies that the
Val-to-Ala substitution at the COCO-VA site has likely preceded
non-synonymous substitutions at the two other ORF5 sites, 242
and 280, and thus might have prompted those.
The above results revealed strong patterns of phylogenetic
association for seven sites across the TSPyV genome. The emer-
gence and proliferation of these associations are open to different
interpretations (see Discussion), which include constrained evo-
lution of the TSPyV variants.
Genetic context of the non-synonymous substitutions in ST and MT of
TSPyV
Next, we analyzed the genetic context of the abovementioned
non-synonymous variations in TSPyV. The ORF1-encoded H133Y
variation is observed at the most variable position of an otherwise
highly conserved genomic region and is located between the two
CXCXXC Zinc-ﬁnger motifs and adjacent to the invariant His resi-
due (Fig. S4). Thus, position 133 is under lower constraints than its
neighboring positions. Likewise, the ORF5-encoded H280R varia-
tion is located in the most divergent region of the genomes of
TSPyV and its two closest relatives, OraPyV1 and Ateles paniscus
polyomavirus (AtPPyV1) (Fig. S5). In contrast, the I242T variation
is in close proximity to the A245V variation at the COCO-VA site
and is located within the ORF5m2, one of the four most conserved
motifs of ORF5 (Lauber et al., 2015). The evolution of this motif ishighly constrained by the LT LXCXE motif encoded by the over-
lapping ORF2. Particularly, the A245V variation represents the full
spectrum of residue variation possible at this position, which was
identiﬁed to experience accelerated COCO-VA toggling in ORF5-
encoding polyomaviruses indicative of positive selection (Lauber
et al., 2015).
Structural context of the non-synonymous substitutions in ST and MT
of TSPyV
Tertiary structure of the H133Y variants of the TSPyV ST/MT
domain was modeled using the solved structure of this domain for
SV40, but this did not reveal any notable differences that could be
attributed to the Tyr/His variation (data not shown).
The amino acid variations I242T, A245V and H280R are located
in the Pro-rich and intrinsically disordered region of MT/ALTO
(Fig. 6). Furthermore, this domain contains a large number of Ser,
Thr and Tyr residues partially conserved in TSPyV, OraPyV1 and
AtPPyV1 (Fig. S5), which could present targets for regulatory
phosphorylation as demonstrated for MPyV (Fluck and Schaff-
hausen, 2009). Because of this characteristic sequence context and
a relatively high local sequence conservation of the ORF5m2 motif,
the latter was regarded as a short linear motif (SLiM) (Lauber
et al., 2015). Consequently, the I242T and A245V substitutions
could affect MT/ALTO function through the ORF5m2 SLiM as we
proposed earlier (Lauber et al., 2015).Discussion
In this report we describe the evolution of TSPyV in humans,
which is the ﬁrst insight of this kind for a polyomavirus of the Ortho-
I genogroup. In agreement with observations on other poly-
omaviruses, we have identiﬁed the NCCR as the predominant site of
genetic variation in TSPyV. For the ﬁrst time for a polyomavirus cir-
culating in a natural host to our knowledge, we have observed a site
under positive selection, which has experienced repeated non-
synonymous substitutions in the exon common to ST/MT antigen
transcripts. Furthermore, we have detected co-variation of seven sites
across the TSPyV genome, including two experiencing non-
synonymous substitutions in ORF5. The fourth non-synonymous
substitution happened at the COCO-VA site that was reported to be
under positive selection during inter-species adaptation of Ortho-I
polyomaviruses (Lauber et al., 2015), indicating a connection
between micro- and macro-evolution of polyomaviruses.
TSPyV is one of the few polyomaviruses with an either estab-
lished or highly probable link to pathology in humans (Kazem et al.,
2012; Kazem et al., 2014). In total, we have analyzed TSPyV genome
sequences from 13 individuals, 12 of which were TS patients that
represent 40% of the reported TS cases worldwide (Kazem et al.,
2013b). Such high coverage makes this dataset highly inclusive for
individuals suffering from TS, despite being small compared to
those available for other characterized polyomaviruses from the
Ortho-II genogroup (Firth et al., 2010; Krumbholz et al., 2009;
Shackelton et al., 2006). We believe that the obtained results are
relevant beyond this patient cohort. Indeed, one of the analyzed
sequence in this study (TSPyV-WK164) that was reported from a TS-
asymptomatic immunocompromised patient (Siebrasse et al., 2012a)
carries only one unique A224T substitution in the NCCR region, and
otherwise differs just by two substitutions from TSPyV-0510 of a TS
patient (Figs. 2 and 3). Furthermore, immunocompetent individuals
must have been involved in virus transmission between the sur-
veyed patients, unless the immunocompromised (TS) patients are
epidemiologically isolated from the rest of the human population
known to be up to 70% TSPyV-seropositive (Chen et al., 2011;
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blue (high) for beta-sheet; transmembrane helices (magenta); intrinsic structural disorder, scores for disordered regions were calculated as a consensus over eight pre-
dictors; and Pro residue density distribution. The top three assignments were assisted with the Disorder Prediction MetaServer. The Pro distribution was calculated using a
three-amino-acid window along the MT sequence of TSPyV. Dashed line, the average number of Pro residues according to ST, LT, MT, VP1, and VP2 sequences. For more
details see M&M and our recent publication (Lauber et al., 2015).
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this preposition seems unreasonable.
Although our samples were collected over 16 years, the actual
time-frame of substitution accumulation may be as large as the
time difference between the years of the most recent sample col-
lection (2012) and the birth of the oldest patient (1940), which is 72
years, due to peculiarities of polyomavirus biology. The large dif-
ference between the above two numbers (56 years) presents a
likely major source of uncertainty of our estimates of evolutionary
rate and tMRCA of TSPyV by a relaxed molecular-clock framework
using the dates of sample collection (unpublished observations). We
chose not to present these results here. Another source of uncer-
tainty is the lack of reliable estimates of the background mutation
rate for polyomaviruses, despite broad acknowledgment of the high
ﬁdelity of the host DNA polymerase mediating polyomavirus gen-
ome replication. Also unknown is the replication rate (generation
time) of polyomaviruses during natural infection that may be pri-
marily determined by the duration of virus latency in the infected
individual. However, virus latency alone may not explain the
observed extraordinary genetic similarity between some TSPyV
variants. For instance, genomes of the two TSPyV pairs, 0910-0304
and 1197–1412, are identical or differ by just a single nucleotide
substitution, respectively, while being collected from infected
patients six and ﬁfteen years apart. According to the literature,
similarly striking examples of extraordinary pairwise similarity
have been observed before for other human polyomaviruses,
including BKPyV (Zheng et al., 2007), MCPyV (Schowalter et al.,
2010), WU (Bialasiewicz et al., 2010) and KI polyomaviruses (Bia-
lasiewicz et al., 2007), which were isolated from individuals resid-
ing in different countries and/or at different time points. Such small
divergence of polyomaviruses in our and other studies could be
explained by very low mutation rates, prolonged virus latency,
strong purifying selection, or a combination of either of these fac-
tors (Duffy et al., 2008; Firth et al., 2010). Based on the strongphylogenetic association and co-variation of seven SNPs, including
two out of four non-synonymous SNPs, we implicate purifying
selection in the evolution of TSPyV. We observed only four sites
with amino acid variations in TSPyV, affecting ORF1 and ORF5.
To identify ORF5 in TSPyV, unknown at the very beginning of
this study (van der Meijden et al., 2010; Kazem et al., 2013a) but
discovered in parallel by others (Carter et al., 2013), and to explore
its implications for TSPyV and other polyomaviruses we developed
a new format of depicting genome-related information in a plot
that separates genome organization from genome expression and
genetic variation (Fig. 1; see M&M for details). We believe this
format provides a consistent and insightful way of presenting
genomic data for polyomaviruses.
ORF5 was found to be the predominant place of non-synonymous
substitutions during circulation of TSPyV in human population (this
study) as well as the most profound genomic changes of Ortho-I
polyomaviruses during their divergence in many hosts (Carter et al.,
2013; Lauber et al., 2015). Despite being exceptional, the evolution of
ORF5 is evidently coordinated with that of other regions at both intra-
and inter-polyomavirus species levels. We identiﬁed sets of covarying
sites representing ORF5 and VP1, and ORF5, ORF2 and NCCR regions of
the TSPyV genome, and we (Lauber et al., 2015) and others (Carter
et al., 2013) observed a phylogenetic association of ORF5 with most
conserved genome regions in the majority of Ortho-I polyomaviruses.
This agreement at the levels of micro- and macro-evolution reveals
that ORF5 deserves further studies.
According to our phylogenetic analysis, the H133Y variation in
ST/MT of TSPyV resulted from recurrent fourth/back substitution
(toggling) in the ORF1-encoded position, producing a typical sig-
nature of positive selection and suggesting its involvement in
adaptation of TSPyV. In contrast, the other three sites with
observed amino acid variation could have been generated with
just a single substitution at the MT position 242, 245, and 280 in
the respective TSPyV ancestors. The evolutionary origin of this
S. Kazem et al. / Virology 487 (2016) 129–140 137pattern is open to two interpretations. Some or all of these three
substitutions could have been ﬁxed as a result of separate bottle-
neck events during neutral evolution. Alternatively, these sub-
stitutions could have been driven by episodic positive selection.
Our quantitative analysis, which was complicated by the overlap of
ORF5 with ORF2 and the small size and diversity of the analyzed
dataset, did not provide a conclusive evidence for the latter.
However, several considerations that we list below are most
compatible with the positive selection scenario.
First, two of these substitutions (242 and 280) were accepted
during transition between some of the most deeply rooted inter-
mediate ancestors leading to two major contemporary lineages of
TSPyV (TSI and TSII), while the third one (245) more likely than
less may have mutated very early. Second, all three substitutions
are genetically segregated within a small region of 114 nts (2.5%
of the genome) rather than scattered over the genome as would be
expected under neutral evolution. Third, they are observed in a
single ORF, ORF5, while three other ORFs, ORF2-ORF4, remain
unaffected. Fourth, under the model of neutral evolution and with
the constraints imposed by ORF5 codons, the frequency of
synonymous substitution in the ORF2 region overlapping with
ORF5 is expected to be lower than that in the downstream part of
ORF2, according to prior research with overlapping genes (Miyata
and Yasunaga, 1978; Sabath et al., 2012). However, these fre-
quencies in the two regions are rather similar in TSPyV: 6.7 and
6.2 per 1000 nts of the ORF2/ORF5 overlap and the ORF2-only,
respectively. Fifth and ﬁnally, the A245V variation corresponds to
the recently described toggling at the COCO-VA site, which was
found to be accelerated and under positive selection in a large
panel of Ortho-I polyomavirus species during inter-species evo-
lution (Lauber et al., 2015). According to the model of neutral
evolution of the COCO-VA toggling developed in that study, the
toggling is highly unlikely due to chance to observe during intra-
species divergence of a polyomavirus.
Because of the availability of viruses with each allele, Ala and
Val, at the COCO-VA site and the overall low sequence diversity of
the TSPyV isolates, TSPyV offers a unique model to study the
molecular basis and functional consequences of COCO-VA toggling
for adaptation of polyomaviruses to host in general.Material and methods
Samples, DNA extraction and PCR ampliﬁcation
As described previously (Kazem et al., 2012), DNA was extracted
from ten TS samples in our laboratory, and extracted DNA was
received from three TS samples. An overview of all TSPyV isolates
analyzed in this study and their whereabouts is given in Table 1. The
DNA isolates were ampliﬁed by PCR with the help of 18 TSPyV-
speciﬁc primer-pairs (Table S1). This resulted in the generation of
eighteen overlapping TSPyV DNA fragments of 266–613 base-pairs in
length that cover the whole TSPyV genome (Fig. S1A). Ten nanogram
input DNA was used in a total volume of 50 μl containing 15 pmol/μl
of each primer, 2.5 U of Pfu DNA polymerase, 1x Pfu buffer and
15 pmol/μl of dNTP's as ﬁnal concentrations. A 3-step PCR ampliﬁ-
cation was performed; starting with 5 min at 95 °C, followed by 30
cycles of 1 min at 95 °C, 1 min at 56 °C and 2 min at 72 °C, and
ﬁnalized with 10 min at 72 °C. Subsequently, one unit of GoTaq DNA
polymerase was added to the PCR reaction, to generate an adenine-
base overhang for the subsequent TOPO(TA)-cloning (Invitrogen,
California, USA), and the reaction was incubated for an additional
10 min at 72 °C. PCR products were assessed for length by gel-
electrophoresis (Fig. S1B) and cloned directly. In case of multiple,
potentially nonspeciﬁc products detected on gel, bands of the
expected length were isolated from gel using the QIAEX II gelextraction kit (QIAGEN, California, USA) and then cloned into TOPO
(TA) vector. The amplicons generated from samples TSPyV-1211, 1312
and 1412 were puriﬁed with GeneJET PCR Puriﬁcation Kit (Fermen-
tas) and subsequently sequenced directly in both directions.
Cloning, sequencing and SNP analysis
TOPO-cloned plasmid DNA was isolated from at least three inde-
pendently grown cultures and sequenced using the BigDye Terminator
v1.1 cycle sequencing kit (Applied Biosystems, California, USA) in the
ABI Prism 3130 Genetic analyzer, according to the manufacturer's
instructions. M13-forward or M13-reverse primers were used to
amplify the ﬂanking TSPyV sequences inserted into the pCRII-TOPO
vector. Obtained sequences were assembled into one contig with CLC
Main Workbench 6 (CLC Bio; Aarhus, Denmark). All generated com-
plete contigs, including the sequence of TSPyV-0109 (NC_014361) (also
serving as the reference TSPyV genome) (van der Meijden et al., 2010)
and TSPyV-WK164 (JQ723730 ) (Siebrasse et al., 2012a), were aligned
using CLC Main Workbench 6 (CLC Bio; Aarhus, Denmark) and SNPs
were analyzed. All viral sequences obtained in this study were
deposited into GenBank and the corresponding assigned accession
numbers are documented in Table 1.
Splice-donor and splice-acceptor site prediction
Putative donor-acceptor splice sites were calculated under
default settings using the web-based Human Splice Finder pro-
gram (http://www.umd.be/HSF) (Desmet et al., 2009). Sites were
searched in the 120 nucleotides (nts) sequence separating ORF1
and ORF5. The experimentally identiﬁed donor-acceptor sites for
the MT mRNAs of HaPyV (NC_001663) (HSF scores: donor, 76% and
acceptor, 92%) and MPyV (NC_001515) (HSF scores: donor, 89% and
acceptor, 86%) were predicted by this program as best in-frame
sites. For TSPyV (NC_014361), only one in-frame donor-acceptor
coordinate was observed (HSF scores: donor, 93% and acceptor,
74%). Illustration of the ORF1 and ORF5 splicing was generated
with Adobe Illustrator CS5 software (Fig. S2).
Visualization of ORF organization, transcriptome and genetic varia-
tion in TSPyV
To facilitate analyses described in this manuscript and commu-
nication of the obtained results, we have developed and used a new
format for the presentation of viral genome-based data (see also (van
der Meijden et al., 2015)). The currently used formats focus on pre-
senting transcripts and differ primarily in choice of the direction for
the early and late transcripts, either of which can be used as running
clock- or counter clockwise. On the other hand, presentation of ORFs
(genomic organization) is given less attention in polyomaviruses. In
the format introduced here, ORFs and transcripts are presented in
separate layers (Fig. 1) that reveal their complexity and relation in
detail. Particularly, ORFs are depicted in three positive (þ1, þ2, þ 3)
and three negative (1, 2, 3) RFs that encode late and early
transcripts, respectively. For the purpose of this study, ORF is deﬁned
as a region of a RF that is ﬂanked by two stop codons; only a portion of
this may be actually expressed. As we show elsewhere in this
manuscript, these details are crucial for understanding of the biology
of TSPyV as well as other polyomaviruses, particularly when combined
with genetic variation that is presented in another layer separating
those for genome and transcriptome (Fig. 1).
Evolutionary analyses of TSPyV genomes
Genomes of 13 TSPyV and other polyomaviruses available at
the Genbank/RefSeq database on February 2013 were downloaded
into the Viralis platform (Gorbalenya et al., 2010). The Muscle
S. Kazem et al. / Virology 487 (2016) 129–140138program (Edgar, 2004) was used to generate family-wide multiple
amino-acid alignments for VP1, VP2 and LT, followed by manual
curation (see also (Lauber et al., 2015)). The alignment of TSPyV
isolates and the closely related Bornean orangutan polyomavirus
(OraPyV1) was extended genome-wide at the nucleotide level.
Multiple sequence alignments of three data sets (DS) were sub-
mitted to phylogeny reconstruction and other evolutionary ana-
lyses: (1) a complete genome alignment of the 13 TSPyVs (DS1),
(2) a complete codon-based genome alignment of the 13 TSPyVs
and OraPyV1 (DS2), and (3) a concatenated codon alignment that
included the ﬁve ORFs of the 13 TSPyV genomes (DS3).
Bayesian phylogenetic reconstruction was performed using
BEAST version 1.7.4 (Drummond and Rambaut, 2007). For DS2 the
dates of virus isolation were incorporated in the analysis in order to
estimate the time of divergence of ancestral nodes in the tree. The
dates for TSPyV isolates are shown in Table 1; the OraPyV1 isolate
originates from 1996 (Ernst Verschoor, personal communication).
The HKY nucleotide substitution model (Hasegawa et al., 1985) (DS1
and DS2) was used; for each data set, rate heterogeneity among
sites was modeled using a gamma distribution with four categories,
and a relaxed molecular-clock approach was tested against the
strict molecular-clock approach (Drummond et al., 2006). The latter
was favored for DS1 (Goodman, 1999), whereas the relaxed
molecular-clock approach was superior for DS2. Markov chain
Monte Carlo (MCMC) chains were run for 20 million steps (DS1 and
DS2) and the ﬁrst 10% were discarded as burn-in. Convergence of
the runs was veriﬁed and parameter estimates, including evolu-
tionary rate and the time of divergence of the most recent common
ancestor (tMRCA) estimates, were obtained using Tracer Tracer v1.4.
(www.beast.bio.ed.ac.uk/Tracer).
Distance-based phylogenetic reconstruction was performed
using the APE package in R (Paradis et al., 2004).
Sites under positive and negative selection were identiﬁed using
the Datamonkey webserver (Kosakovsky Pond and Frost, 2005a).
The SLAC, FEL, IFEL, REL, MEME, and FUBAR methods were applied
under default parameters on DS3. These methods implement dif-
ferent approaches for the detection of positive and negative selec-
tion, as well as episodic selection. For a detailed discussion on the
different approaches see (Kosakovsky Pond and Frost, 2005a;
Kosakovsky Pond and Muse, 2005b; Kosakovsky Pond and Frost,
2005c; Murrell et al., 2013). Coevolution of genomic positions was
assessed by using the Spidermonkey method (Poon et al., 2007) at
the Datamonkey webserver using DS1.
Recombination analysis was performed using Single Break
Point Recombination (SBP) and Genetic Algorithm Recombination
Detection (GARD) at the Datamonkey web site (Kosakovsky Pond
et al., 2006).
Reconstruction of ancestral sequence states has been per-
formed using the PAML package (Yang, 1997).
Detection of selection in different ORFs was conducted using
McDonald–Kreitman test with Jukes&Cantor correction (MKT-JC)
as implemented at the MKT web-site (Egea et al., 2008).
Phylogenetic association of amino acid variations and place of TSPyV
origin
We used the BaTS tool (Parker et al., 2008) to test whether
there is any association of the observed amino acid variation at a
particular site with lineages in the underlying phylogeny. To do so,
we treated the amino acids observed at a particular site as the
varying trait. Brieﬂy, BaTS compares the observed distribution of
the trait values (amino acid residues in this case) among the
lineages in the phylogeny against the null hypothesis of randomly
distributed trait values using the following three test statistics:
parsimony score (PS) (Slatkin and Maddison, 1989), association
index (AI) (Wang et al., 2001), and maximum monophyletic cladesize (MC) (Parker et al., 2008). We also used this BaTS-based
approach to analyze the association of the country of residence
and gender of patients with lineages in the tree.
Bioinformatics analyses of the putative ST and MT
Sequence logos were compiled using the WebLogo server
(Crooks et al., 2004; Schneider and Stephens, 1990). Multiple
sequence alignment of ST was generated with the CLC Main
Workbench (CLC Bio v6.6; Aarhus, Denmark) using the programs
default options. Secondary structure, transmembrane helix, and
disorder prediction of MT sequences were generated using the
Disorder Prediction MetaServer (www-nmr.cabm.rutgers.edu/
bioinformatics/disorder), which reports consensus results of the
following eight predictors: DISEMBL (Linding et al., 2003a), DIS-
OPRED (Ward et al., 2004), DISpro (Deng et al., 2009), FoldIndex
(Prilusky et al., 2005), GlobPlot2 (Linding et al., 2003b), IUPred
(Dosztanyi et al., 2005), RONN (Yang et al., 2005), and VSL2 (Vucetic
et al., 2003). The prediction of disorder was considered signiﬁcant if
at least four predictors gave a hit. Amino acid composition and
other sequence features of MT and LT were analyzed and plotted
using custom R scripts (www.R-project.org).
Accession numbers
Accession numbers of virus genomes utilized in the study are
shown in Table 1.Acknowledgments
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